Penserra Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,587
| Closed | -$7K | – | 1024 |
|
|
2025
Q1 | $7K | Buy |
1,587
+239
| +18% | +$1.05K | ﹤0.01% | 903 |
|
|
2024
Q4 | $9K | Buy |
1,348
+74
| +6% | +$494 | ﹤0.01% | 1034 |
|
|
2024
Q3 | $7K | Buy |
1,274
+392
| +44% | +$2.15K | ﹤0.01% | 907 |
|
|
2024
Q2 | $6K | Buy |
+882
| New | +$6K | ﹤0.01% | 1042 |
|
|
2021
Q4 | – | Sell |
-910
| Closed | -$10K | – | 1356 |
|
|
2021
Q3 | $10K | Buy |
910
+35
| +4% | +$385 | ﹤0.01% | 1353 |
|
|
2021
Q2 | $8K | Buy |
875
+30
| +4% | +$274 | ﹤0.01% | 1284 |
|
|
2021
Q1 | $11K | Buy |
845
+85
| +11% | +$1.11K | ﹤0.01% | 1020 |
|
|
2020
Q4 | $8K | Buy |
+760
| New | +$8K | ﹤0.01% | 945 |
|